EC Paediatrics

Background and Aim: Nosocomial infections pose an important threat to patient safety and recovery. The present study aimed to evaluate the effect of central line bundle compliance on central line associated blood stream infections in neonatal intensive care units.

Methods: The six components of bundle compliance were Hand hygiene, adherence to aseptic techniques including sterile gloves, gown, surgical cap and mask, preparing skin with 2% Chlorhexidine in 70% alcohol, optimal catheter site selection (Internal jugular or subclavian vein), standardized tubing change and daily review of catheter necessity. Compliance of CL bundle and CLABSIs were measured in the neonatal ICU from January 2019 to December 2019.

Results: A total of 2 CLABSI were reported of the patients who completed CL bundles. The major causes of central line infection included contamination, suboptimal environment of care, improper documentation and evaluation of central venous catheter dressing integrity, issues with equipment and suppliers and lack of knowledge.

Conclusion: This study provides evidence that CL bundle compliance is essential in preventing CLABSI in intensive care units. This could largely avoid neonatal deaths associated with infections.

 Keywords: Central Venous Catheters; Catheter-Related Infections; Intensive Avoid; Neonatal; Central Line Bundle

1. Boev C and Kiss E. “Hospital-acquired infections: Current trends and prevention”. Critical Care Nursing Clinics of North America 1 (2017): 51-65.
2. Sikora A and Zahra F. “Nosocomial Infections”. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2024).
3. Suetens C., et al. “Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017”. Eurosurveillance 46 (2018): 1800516.
4. Allegranzi B., et al. “Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis”. Lancet9761 (2011): 228-241.
5. Klevens RM., et al. “Estimating health care-associated infections and deaths in U.S. hospitals, 2002”. Public Health Reports 2 (2007): 160-166.
6. Allegranzi B., et al. “Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis”. Lancet9761 (2011): 228-241.
7. Goudie A., et al. “Attributable cost and length of stay for central line-associated bloodstream infections”. Pediatrics6 (2014): e1525-e1532.
8. Bell T and O'Grady NP. “Prevention of central line-associated bloodstream infections”. Infectious Disease Clinics of North America 3 (2017): 551-559.
9. Jernigan JA., et al. “Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017”. New England Journal of Medicine 14 (2020): 1309-1319.
10. Pronovost P., et al. “An intervention to decrease catheter-related bloodstream infections in the ICU”. New England Journal of Medicine 26 (2006): 2725-2732.
11. Miller MR., et al. “Decreasing PICU catheter-associated bloodstream infections: NACHRI’s quality transformation efforts”. Pediatrics2 (2010): 206-213.
12. Wheeler DS., et al. “A hospital-wide quality-improvement collaborative to reduce catheter-associated bloodstream infections”. Pediatrics4 (2011): e995-e1004, quiz e1004-e1007.
13. Coffey M., et al. “Association between hospital acquired harm outcomes and membership in a national patient safety collaborative”. JAMA Pediatrics9 (2022): 924-932.
14. Jeong IS., et al. “Effect of central line bundle on central line-associated bloodstream infections in intensive care units”. American Journal of Infection Control 8 (2013): 710-716.
15. Furuya EY., et al. “Central line bundle implementation in US intensive care units and impact on bloodstream infections”. PLoS One1 (2011): e15452.
16. Longmate AG., et al. “Elimination of central-venous-catheter-related bloodstream infections from the intensive care unit”. BMJ Quality and Safety 2 (2011): 174-180.
17. Ong A., et al. “Trends in central line-associated bloodstream infections in a trauma-surgical intensive care unit”. Archives of Surgery 3 (2011): 302-307.
18. McLaws ML and Burrell AR. “Zero risk for central line-associated bloodstream infection: are we there yet?” Critical Care Medicine 2 (2012): 388-393.
19. Wang W., et al. “Prevention of peripherally inserted central line-associated blood stream infections in very low-birth-weight infants by using a central line bundle guideline with a standard checklist: a case control study”. BMC Pediatrics 15 (2015): 69.
20. Rosenthal VD., et al. “Findings of the International Nosocomial Infection Control Consortium (INICC), part III: effectiveness of a multidimensional infection control approach to reduce central line-associated bloodstream infections in the neonatal intensive care units of 4 developing countries”. Infection Control and Hospital Epidemiology 3 (2013): 229-237.
21. Sacks GD., et al. “Reducing the rate of catheter-associated bloodstream infections in a surgical intensive care unit using the Institute for Healthcare Improvement Central Line Bundle”. American Journal of Surgery 6 (2014): 817-823.
22. Heeg P. “Nosocomial infections in newborn nurseries and neonatal intensive care units”. International Journal of Infectious Diseases 1 (2006).
23. Zafar N., et al. “Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate”. Archives of Pediatrics and Adolescent Medicine 10 (2001): 1098-1104.
24. Lee J. “Catheter-related bloodstream infections in neonatal intensive care units”. Korean Journal of Pediatrics 9 (2011): 363-367.
25. Gaynes R., et al. “Nosocomial infections among neonates in high-risk nurseries in the United States”. Pediatrics 3 (1996): 357-361.
26. Ratna AS., et al. “Effect of central line bundle implementation on central line-associated bloodstream infection rates in NICU in KSA”. International Journal of Infection Control2 (2016).